Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial
NCT00455494
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
DRUG:
AQ-13
Sponsor
Tulane University Health Sciences Center
Collaborators
[object Object]